Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Keren Rouvinov
Observed names:
K Rouvinov,
K. Rouvinov,
K.R. Rouvinov,
Rouvinov, Keren
Institutions:
Ben-Gurion University of the Negev,
Soroka Medical Center
Observed institutions:
Ben-Gurion University of the Negev,
Tel Aviv University,
Tel Aviv Sourasky Medical Center,
Soroka Medical Center,
Meir Medical Center
ORCID:
0000-0002-8273-4723
Observed ORCID:
0000-0002-8273-4723
OpenAlex ID:
A5084245628
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
2021
·
Thomas Powles
, Tibor Csőszi
, et al.
·
The Lancet Oncology
·
700
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
2022
·
Smith, Matthew, R.
, Scher, Howard
, et al.
·
Macquarie University
·
218
Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
2013
·
Daniel Keizman
, Maya Gottfried
, et al.
·
The Oncologist
·
67
A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
2013
·
Mark Krauthamer
, Keren Rouvinov
, et al.
·
Oncology
·
67
Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database
2017
·
D Keizman
, M O Fosboel
, et al.
·
Prostate Cancer and Prostatic Diseases
·
50
Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer
2023
·
Bar Kaufman
, Orli Abramov
, et al.
·
Science Advances
·
38
PDF
A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors
2022
·
Walid Shalata
, Sarah Weissmann
, et al.
·
Cancers
·
38
PDF
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study
2021
·
Daniel Keizman
, Moshe Frenkel
, et al.
·
Nutrients
·
31
PDF
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma
2016
·
Daniel Keizman
, Maya Ish-Shalom
, et al.
·
Clinical Genitourinary Cancer
·
27
The impact of the COVID-19 pandemic on colorectal and gastric cancer diagnosis, disease stage and mortality
2022
·
Naim Abu-Freha
, Reut Hizkiya
, et al.
·
Frontiers in Medicine
·
25
PDF
Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study
2022
·
Waleed Kian
, Melanie Zemel
, et al.
·
Medicine
·
23
Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis
2021
·
Waleed Kian
, Melanie Zemel
, et al.
·
Anti-Cancer Drugs
·
22
Rapid Response to Nivolumab in a Patient With Sarcomatoid Transformation of Chromophobe Renal Cell Carcinoma
2017
·
Keren Rouvinov
, Lidia Osyntsov
, et al.
·
Clinical Genitourinary Cancer
·
22
Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib
2016
·
Daniel Keizman
, David Sarid
, et al.
·
The Oncologist
·
21
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience
2023
·
Keren Rouvinov
, Gal Mazor
, et al.
·
Journal of Personalized Medicine
·
20
PDF
Nivolumab-Induced Systemic Capillary Leak Syndrome as an Ultra Rare Life-Threatening Phenomenon of Late Toxicity and Intravenous Immunoglobulin Efficacy
2021
·
Ilya Polishchuk
, Alexander Yakobson
, et al.
·
Immunotherapy
·
20
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study
2023
·
DANIEL KEIZMAN
, Moshe Frenkel
, et al.
·
Nutrients
·
19
PDF
Testicular Metastasis from Renal Cell Carcinoma: A Case Report and Review of the Literature
2017
·
Keren Rouvinov
, Endre Z. Neulander
, et al.
·
Case Reports in Oncology
·
18
Unexpected Adverse Events of Immune Checkpoint Inhibitors
2023
·
Walid Shalata
, Alexander Yakobson
, et al.
·
Life
·
16
PDF
Evaluation of the optimal strategy in men with a single unilateral suspicious lesion on MRI undergoing transperineal MRI/ultrasound fusion prostate biopsy
2023
·
Igor Yusim
, Elad Mazor
, et al.
·
The Prostate
·
15
PDF
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
2019
·
Keren Rouvinov
, Karen Nalbandyan
, et al.
·
Case Reports in Oncology
·
15
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
2015
·
Daniel Keizman
, Keren Rouvinov
, et al.
·
Cancer Research and Treatment
·
11
PDF
Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors.
2014
·
Dana Livne-Segev
, Maya Gottfried
, et al.
·
PubMed
·
10
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
2023
·
Keren Rouvinov
, Eran Levanon
, et al.
·
Frontiers in Oncology
·
9
PDF
Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases
2025
·
Walid Shalata
, Rashad Naamneh
, et al.
·
Medical Sciences
·
7
PDF
Show more works
View as search
Works count:
100
Citation count:
1,601
H-index:
18
I10-index:
23
Year
Topic
Type